Search PubMed⌕ Search

Biomedical subjects

H Takagi

Publications and source records attributed to H Takagi.

1,504 records · Page 84Linked to original sources

Expression of sialyl Lewis(x) in hepatocellular carcinoma.

BACKGROUND/AIMS: Expression of the sialyl Lewis(x) antigen, a cell adhesion molecule, was studied immunohistochemically in patients with hepatocellular carcinomas. MATERIALS AND METHODS: Fifty-six patients who underwent curative hepatic resections from July 1984 to October 1990 were studied. RESULTS: Hepatocellular staining patterns of the sialyl Lewis(x) in cancerous or noncancerous regions were divided into the three categories of high grade (HG), medium grade (MG), and low grade (LG). In cancerous regions, HG:54% (30/56); MG:13% (7/56); LG:34% (19/56). In noncancerous regions, HG: 86% (48/56), MG:4% (2/56), LG:11% (6/56). Patients with LG or MG sialyl Lewis(x) expression in cancerous regions had vascular invasion more frequently, and larger maximum diameters than HG patients, both with statistical significance (p<0.01, p<0.05, respectively). The 20 cases in which the expression of sialyl Lewis(x) in cancerous regions was downgraded compared with noncancerous regions (from HG in noncancerous regions to MG or LG in cancerous regions; from MG in noncancerous regions to LG in cancerous regions), also had vascular invasion significantly more frequently than the other 36 cases (p<0.02). CONCLUSION: These results lead us to speculate that the diminishing change of hepatocellular sialyl Lewis(x) expression with malignant transformation, or the small amounts of hepatocellular sialyl Lewis(x) expression in cancerous regions, are related to tumor spread of hepatocellular carcinoma.

Carcinoma, Hepatocellular↗

The association of metastasis with the expression of adhesion molecules in cell lines derived from human gastric cancer.

Peritoneal dissemination and hepatic metastasis commonly occur after patients with gastric cancer have undergone surgery. The presence of metastasis after surgery is sure to affect the prognosis of patients with gastric cancer. We conducted in vitro and in vivo studies to assess the role of adhesion molecules in this process, using 2 cell lines derived from human gastric cancer. Although both cell lines expressed several adhesion molecules to varying degrees, NUGC-4 cells, which disseminated early after inoculation into the abdominal cavity of nude mice accompanied by the formation of bloody ascitic fluid, predominantly expressed CD44H. However, MKN74 cells, which demonstrated hematogenous metastasis in the liver after inoculation into the spleen of nude mice, strongly expressed the sialyl Lewis(x) antigen (s-Le(x)), but did not express CD44H at all. When the binding of both these cancer cells to human umbilical vein endothelial cells was examined it was found that MKN74 cells adhered more strongly than NUGC-4 cells. The adhesion of cancer cells to endothelial cells was inhibited by treatment with antibodies against s-Le(x) and E-selectin. In the liver metastasis model of nude mice, treatment with anti-s-Le(x) antibodies significantly inhibited the development of MKN74 cell liver metastasis, both in the number of tumor nodules and in liver weight. NUGC-4 cells adhered to monolayers of mesothelial cells more strongly than MKN74 cells. The adhesion of NUGC-4 cells to these cells was partially inhibited by antibodies either against CD44H or the beta 1 subunit of integrin, but was completely blocked by a combination of these 2 antibodies. These antibodies markedly inhibited the dissemination of NUGC-4 cells in the peritoneal cavity of nude mice, and prolonged their mean survival time. These findings suggest that s-Le(x) and E-selectin mediate the adhesion of gastric cancer cells to endothelial cells, and CD44H and beta 1 integrin play important roles in the initial attachment of gastric cancer cells to mesothelial cells. It is possible that compounds that interfere with the function of cell adhesion molecules may decrease the incidence of gastric cancer metastasis.

Animals↗

Increased concentration of soluble E-selectin in the sera of breast cancer patients.

E-selectin which is expressed on endothelial cells plays an important role in the adhesion of cancer cells to the vascular endothelium, being the ligand for a carbohydrate antigen expressed on cancer cells. In this study, the clinical usefulness of this protein was examined. E-selectin was expressed on the endothelial cells of the small vessels adjacent to the cancer nests in 63 of the 104 (60.6%) primary tumors of breast cancer. The expression of E-selectin in locations adjacent to the cancer nests was more pronounced than that in distant ones. The mean value of serum soluble E-selectin (ng/ml) was 38.3 in benign breast disease, 47.8 in those with no evidence of recurrence, 49.4 in stage I/II primary breast cancer, 75.8 in stage III/IV primary breast cancer, and 93.7 in recurrent breast cancer. The mean value of serum soluble E-selectin was 106.2 ng/ml in patients with distant metastases, and 50.4 ng/ml in those with no evidence of distant metastases. Thus, the concentration of soluble E-selectin was significantly elevated in the sera of patients with distant metastases. These findings suggested that cancer cells induced the expression of E-selectin on endothelial cells and, that serum soluble E-selectin is useful as a tumor marker having a close relationship to metastasis in breast cancer.

Biomarkers, Tumor↗

Hepatic resection for hepatocellular carcinoma with a tumor thrombus extending to inferior vena cava.

The significance of hepatic resection for hepatocellular carcinoma with a tumor thrombus in the inferior vena cava (IVC) is clarified. We operated on 4 patients with HCC who had a tumor thrombus extending to the IVC through the hepatic vein under hepatic vascular exclusion (HVE). In all patients the hepatic resections and thrombectomies were successful without major complication. One patient accompanied with a tumor thrombus in the portal vein had a rash recurrence in the remnant liver and died 6 months after operation. However, three patients without tumor thrombus in the portal vein survived relatively longer post-operatively. Hepatic resection for HCC with tumor thrombus in IVC is acceptable treatment as it is safe. It is considered that better prognoses can be maintained when a tumor thrombus is located only in the hepatic vein, and not in the portal vein.

Aged↗

Postoperative delayed emptying in pylorus-preserving pancreatoduodenectomy using pancreaticogastrostomy: comparison of the reconstruction position.

BACKGROUND/AIMS: We frequently use pancreaticogastrostomy after pylorus-preserving pancreatoduodenectomy (PpPD). Although it is a useful and effective technique, it sometimes requires prolonged delayed emptying. We considered the best position for pancreaticogastrostomy in such a way as to reduce this period of delayed emptying. MATERIAL AND METHOD: From 1991 to 1996, 17 patients whose blood sugar was controlled and who were kept on H2 blocker were selected from among 25 patients who underwent PpPD and were reconstructed by pancreaticogastrostomy. We investigated the history of the relationship between reconstruction position and delayed emptying, reconstruction position and minor leakage, minor leakage and delayed emptying, reconstruction position and stomach mobility without leakage. RESULTS: The delayed emptying was shorter for a reconstruction position in the area above the angulus rather than below it. CONCLUSION: The results suggest that the area above the angulus is the preferred site for pancreaticogastrostomy after PpPD.

Adult↗

Monitoring and regulating latissimus dorsi muscle performance for circulatory assist.

The purposes of this study were monitoring and regulating latissimus dorsi muscle (LDM) performance with muscle internal pressure and thickness, and with burst stimulation parameters, respectively. The unconditioned LDM flap of a pig was connected to a measurement system to examine force and contraction length. Internal pressure was measured using a catheter pressure transducer with a fluid-filled balloon inserted into the muscle, and correlated linearly with force during both contraction and relaxation. During contraction, thickness change correlated linearly with contraction length and the area enclosed within an internal pressure-thickness curve, and the X-axis was correlated linearly with muscle work. Stroke work increased incrementally according to the pulse width up to 6.72 msec or burst rate up to 120 Hz, and then plateaued at 240 Hz. The authors conclude that muscle work during contraction could be monitored with internal pressure and thickness, and that stroke work could be regulated with pulse width or burst rate.

Animals↗

False-positive endotoxemia derives from gauze glucan after hepatectomy for hepatocellular carcinoma with cirrhosis.

BACKGROUND/AIMS: The purpose of this study was to evaluate the occurrence of false-positive endotoxemia after hepatectomy for hepatocellular carcinoma in patients with cirrhosis. The chromogenic conventional limulus test (Toxicolor test) revealed transiently increased blood endotoxin levels after hepatic resection for hepatocellular carcinoma in patients with liver cirrhosis. However, clinical signs of endotoxemia were not observed in all of the cases. METHODOLOGY: Pre- and postoperative changes of blood endotoxin levels and beta-glucan were measured in 20 patients with liver cirrhosis who underwent hepatic resection for hepatocellular carcinoma, using the Toxicolor test, the Endospecy test (which specifically reacts with endotoxin) and the Gluspecy test (which specifically reacts with beta-glucan). The changes in endotoxin levels and beta-glucan in ascitic fluid during surgery were also studied. RESULTS: The Toxicolor test revealed transiently increased blood endotoxin levels, but Endospecy test results were not elevated. The changes in the Gluspecy test were almost the same as in the Toxicolor test. During surgery, beta-glucan levels in the ascitic fluid increased remarkably due to their release from the surgical gauze. Digestion studies using 1-3-beta-D-glucanase on specimens which showed high Toxicolor and Gluspecy test values resulted in a lack of response for both tests. CONCLUSION: The cause of false-positive endotoxemia was determined to be caused by beta-glucan, which was released from the surgical gauze.

Ascitic Fluid↗

Intraoperative radiotherapy for pancreatic carcinoma with hepatic or peritoneal metastases.

BACKGROUND/AIMS: The purpose of this study was to determine the efficacy of intraoperative radiotherapy (IORT) for unresectable pancreatic carcinoma associated with hepatic or peritoneal metastasis. METHODOLOGY: Between 1991 and 1994, 53 patients with pancreatic carcinoma associated with hepatic or peritoneal metastasis underwent surgery. Twenty-four of these patients received IORT, while 29 received no radiation therapy. The efficacy of IORT on the postoperative survival and pain relief for these patients was retrospectively analyzed. RESULTS: Postoperative survival was lowest in the subgroup of patients (n = 18) with both hepatic and peritoneal metastases, and this group did not benefit from IORT (IORT, n = 6; no IORT, n = 12) in terms of survival. Similarly, there was no significant difference in the survival rates between patients undergoing IORT (n = 10) and patients without IORT (n = 11) in the subgroup of patients with hepatic metastasis but without peritoneal metastasis. However, patients with peritoneal metastasis but without hepatic metastasis benefited significantly from IORT (IORT, n = 8; no IORT, n = 6) (p < 0.05). Pain relief following IORT was observed in 9 out of 10 patients who had experienced pain prior to surgery. CONCLUSION: Pancreatic carcinoma associated with peritoneal metastasis but without hepatic metastasis can be palliated by IORT. In addition, pain palliation in patients who require gastrointestinal or biliary drainage can also be achieved by IORT.

Humans↗

Inhibition of establishment of hepatic metastasis in mice by combination gene therapy using both herpes simplex virus-thymidine kinase and granulocyte macrophage-colony stimulating factor genes in murine colon cancer.

Herpes simplex virus-thymidine kinase (HS-tk) gene therapy with ganciclovir (GCV) treatment has been reported to inhibit the tumor growth, which is applied to the gene therapy targeted to the malignant brain tumor. To suppress the tumor growth completely, the authors designed the HS-tk gene therapy in combination with granulocyte macrophage-colony stimulating factor (GMCSF) gene using the hepatic metastatic model of murine colon cancer. The transduction of the HS-tk gene in combination with the GMCSF gene, followed by GCV, showed a complete inhibition of hepatic metastases of murine colon cancer, which was significantly superior to that of HS-tk gene alone. The growth of cancer cells transduced with both HS-tk and GMCSF genes was inhibited in vitro, and long-lasting antitumor immunity after hepatic metastasis of cancer cells transduced with both HS-tk and GMCSF genes was acquired. It is suggested that HS-tk gene therapy in combination with the GMCSF gene is effective for the complete inhibition of hepatic metastasis of murine colon cancer.

Animals↗

A case of solitary metastatic pancreatic cancer from rectal carcinoma: a case report.

A 79 year-old male who had undergone resection of the rectum for rectal cancer was shown to have metastasis to the pancreas 11 years after surgery. The metastatic lesion was located at the tail and body of the pancreas, and was resected with distal pancreatectomy. The same patient also had metastasis to the lung 8 years after initial rectal surgery. Therefore, the course of metastasis to the pancreas was suggested to be from the metastatic lung tumor to the pancreas by hematogenous spread. The patient was considered disease-free 8 months after the pancreatectomy. Recent advances in the technology of diagnostic imaging have facilitated the selection of surgical therapy for metastasis to the pancreas in rectal cancer patients after follow-up by imaging diagnosis.

Adenocarcinoma↗